US labelling update for 'Zetia'

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2003年 / 959卷 / 1期

关键词：

Public Health; Clinical Trial; Adverse Reaction; Myopathy; Safety Profile;

D O I：

10.2165/00128415-200309590-00003

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[41] Sildenafil labelling to be revised in the US and Europe
Reactions Weekly, 1999, 751 (1) : 2 - 2
[42] Safety updates to US labelling for Avinza
Reactions Weekly, 2005, 1077 (1) : 2 - 2
[43] US FDA revises labelling for PPIs
Reactions Weekly, 2010, 1304 (1) : 2 - 2
[44] Revised safety labelling for zanamivir in the US
Reactions Weekly, 2000, 811 (1) : 3 - 3
[45] Zyprexa, Symbyax labelling updated in the US
Reactions Weekly, 2007, 1173 (1) : 2 - 2
[46] US labelling changes for itraconazole and terbinafine
Reactions Weekly, 2001, 852 (1) : 2 - 2
[47] Discovery of Zetia: the long and winding road for the extraordinary journey from ACAT to Zetia to NPC1L1
McKittrick, Brian
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233
[48] Antipsychotic manufacturers update labelling following FDA request
Reactions Weekly, 2004, 998 (1) : 2 - 2
[49] US FDA approves Acetadote labelling updates
Reactions Weekly, 2006, 1093 (1) : 3 - 3
[50] New warnings added to Dexedrine labelling in the US
Reactions Weekly, 2006, 1116 (1) : 3 - 3

← 1 2 3 4 5 →